Indications and uses
For the removal of excess keratin in hyperkeratotic disorders, including scaling associated with psoriasis or thickened skin of palms and soles, corns and calluses.
For the removal of excess keratin in hyperkeratotic disorders, including scaling associated with psoriasis or thickened skin of palms and soles, corns and calluses.
Apply SALYNTRA GEL thoroughly to the affected area and occlude the area at night. Preferably, the skin should be hydrated (soaked in water) for at lest five minutes prior to application. The medication is washed off in the morning. In those areas where occlusion is difficult or impossible, application is washed off in the morning. In those areas where occlusion is difficult or impossible, application may be made m...
salicylic acid 6%
For the removal of excess keratin in hyperkeratotic disorders, including scaling associated with
psoriasis or thickened skin of palms and soles, corns and calluses.
For external use only. Avoid contact with eyes an other mucous membranes. May cause mild irritation. If excessive irritation or sensitivity occurs, discontinue use and consult with your physician.
Do not use on children under 2 years of age. Read package insert carefully.
Flammable. Keep away from heat and open flame. Keep this and all medications out of reach of children.
Apply SALYNTRA GEL thoroughly to the affected area and occlude the area at night. Preferably, the skin should be hydrated (soaked in water) for at lest five minutes prior to application. The medication is washed off in the morning. In those areas where occlusion is difficult or impossible, application is washed off in the morning. In those areas where occlusion is difficult or impossible, application may be made more frequently. Once clearing is apparent, the occasional use of SALYNTRA GEL will usually maintain the remission. Unless hands are being treated, hands should be rinsed thoroughly after application.
Store at controlled room temperature 59 to 86 F (15 to 30 C)
hydroxypropyl cellulose, propylene glycol
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83592-125-60 | GM - Gram | 83592-125 | deaf25aa-a7c4-41d9-9807-46596039a65b | 1 | 2024-04-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83592-125 | 83592-125-60 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HYDROXYPROPYL CELLULOSE, UNSPECIFIED | 9XZ8H6N6OH | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 27eb84f0-2726-5236-e063-6394a90afc8d | ad95f441-40ae-47cf-ab75-baeaa9d6a2fa | 2024-11-27 | Warnings | ad95f441-40ae-47cf-ab75-baeaa9d6a2fa |
Adverse event summaries are temporarily unavailable. Other product information remains available.